Supply of Zovirax Ophthalmic Ointment (aciclovir 3%) resumes
07 June 2016
Resumed supply of Zovirax Ophthalmic Ointment confirmed following a global supply shortage.
The supply shortage was caused by an issue affecting aciclovir, the product’s active pharmaceutical ingredient (API), which resulted in a retail level recall in October 2014.
Following a thorough investigation and resolution of the issue, Zovirax Ophthalmic Ointment is now available in Australia.
Corrective measures have been put in place at the manufacturing site to help prevent this issue from re-occurring.
For more information please visit the TGA website.
GSK is committed to ensuring the highest quality and supply of our medicines and vaccines to patients.